Actively Recruiting

Age: 18Years +
All Genders
NCT06586593

Neoadjuvant Immunotherapy of Operable Metastatic Melanoma in Real Life (GCC)

Led by Centre Hospitalier Universitaire de Besancon · Updated on 2024-09-19

77

Participants Needed

9

Research Sites

92 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study aims to evaluate efficacy and tolerance of real life neoadjuvant immunotherapy in advanced yet operable melanoma. The complete histological response will be assessed.

CONDITIONS

Official Title

Neoadjuvant Immunotherapy of Operable Metastatic Melanoma in Real Life (GCC)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with operable metastatic melanoma (stage III or IV by AJCC staging) treated with neoadjuvant immunotherapy (anti-PD1 or anti-PD1 + anti-CTLA-4), including those whose surgery was cancelled due to disease progression, complete response, or patient refusal
  • Efficacy of neoadjuvant immunotherapy assessed histologically or radiologically
Not Eligible

You will not qualify if you...

  • Diagnosis of uveal melanoma

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 9 locations

1

CHU Angers

Angers, France

Active, Not Recruiting

2

CHU de Besançon

Besançon, France

Actively Recruiting

3

Hôpital Avicenne

Bobigny, France

Active, Not Recruiting

4

CH de Boulogne-sur-Mer

Boulogne-sur-Mer, France

Active, Not Recruiting

5

CHU Clermont-Ferrand

Clermont-Ferrand, France

Active, Not Recruiting

6

Centre de Lutte Contre le Cancer Léon Bérard

Lyon, France

Active, Not Recruiting

7

ICO René Gauducheau

Saint-Herblain, France

Active, Not Recruiting

8

Institut Universitaire de Cancérologie de Toulouse

Toulouse, France

Active, Not Recruiting

9

CH de Valence

Valence, France

Active, Not Recruiting

Loading map...

Research Team

C

Charlée NARDIN, MD PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Neoadjuvant Immunotherapy of Operable Metastatic Melanoma in Real Life (GCC) | DecenTrialz